BioNTech SE - ADR vs Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037 — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Ubs Ag Etracs Crude Oil Shares Covered Call ETN Exp 24th Apr 2037 trades at $45.86. Which is the better fit depends on your goals.
| BNTX | USOI | |
|---|---|---|
Market Cap | $23.31B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $119.34 | $61.17 |
52-Week Low | $83.89 | $42.27 |
Enterprise Value | $6.60B | — |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →USOI is an Exchange-Traded Note (ETN) issued by UBS that provides exposure to a covered call strategy on the United States Oil Fund (USO). It aims to generate high monthly income by capturing option premiums from the hypothetical sale of out-of-the-money call options on oil shares, offering a way to profit from crude oil's volatility even in a flat or range-bound market.
Read more on USOI →